41) Quest Diagnostics' —60 Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 63 Gender: M Phone: 561.366.0084 Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR911482U Requisition: 0021277 Collected: Received: Reported: Test Name LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL 06/24/2016 06/27/2016 10:03 EDT 06/27/2016 16:51 EDT Client #: 17436 56W5265 MOSKOWITZ, BRUCE W UCA/MOSKOWITZ BRUCE MD Attn: **P GR/UNIV.CLINICAL 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401 In Range Out Of Range Reference Range Lab 184 125-200 mg/dL MI 29 L > OR = 40 mg/dL MI 375 H <150 mg/dL MI 80 <130 mg/dL (talc) MI Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 6.3 H NON HDL CHOLESTEROL 155 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 1.1 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 14.2 H Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC PANEL GLUCOSE 90 < OR = 5.0 (talc) mg/dL (talc) mg/